health.am

An advisory panel to the Food and Drug Administration is expected to vote Thursday on whether a drug already used to treat H.I.V. infection should also be approved to…

UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that…

In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails…

California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.

The pill, which is already used to treat…

A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers…

Tall, with dark-green pointy leaves, the neem tree of India is known as the “village pharmacy.” As a child growing up in metropolitan New Delhi, Sonia Arora recalls on…

The pill-a-day approach to HIV prevention can be cost-effective in men who have sex with men, but only in those at high risk for infection, researchers reported.

In a complex…

Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S.…

WASHINGTON: In a major breakthrough in the fight against AIDS, scientists claim to have for the first time shown that human stem cells can be genetically engineered…

Anal cancer is on the rise among HIV-positive women, according to a Montefiore Medical Center study entitled, “High Prevalence of High Grade Anal Intraepithelial Neoplasia in HIV-Infected…

A vaccine that may prevent HIV has been given the green light by the U.S. Food and Drug Administration to begin clinical trials in humans, according to Canadian researchers.

The announcement…

Temporary anti-retroviral therapy during the first stage of HIV infection can delay the time to long-term treatment, researchers reported.

In a randomized trial, early treatment reduced the so-called viral set point…

The FDA has expanded the indication for etravirine (Intelence) to include treatment of HIV-1 in pediatric patients ages 6 and older in combination with other anti-retroviral medication.

The expansion means…

A study in this week’s PLoS Medicine suggests that when people are first infected with HIV (primary HIV infection), temporary treatment with antiretroviral drugs (cART)…

Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in…

Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV)…

A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been…

Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women. Scientists have known for years that traumatized women…

Add one more complication to uncontrolled HIV infection - damaged lungs.

In an observational study, people with uncontrolled HIV infection experienced a loss in lung function at a sharply higher…

HIV patients in the U.S. start treatment earlier than patients elsewhere in the world, according to an analysis of immune system markers presented here.

However, a patient…

More HIV treatment in a community results in fewer new HIV infections, a South African study has revealed.

When HIV treatment coverage reached 20% of the infected population, a surveillance project…

The story of pre-exposure prophylaxis for HIV - using medications to prevent infection - was anything but easy to understand at the Conference on Retroviruses and Opportunistic Infections.

One study…

Scientists, stymied for decades by the complexity of the human immunodeficiency virus, are making progress on several fronts in the search for a cure for HIV infections, a…

A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

A team of researchers at the University of North Carolina at Chapel Hill has successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma. Tackling…